Human Epilepsy Genetics--Neuronal Migration Disorders Study
Launched by HARVARD UNIVERSITY FACULTY OF MEDICINE · Jul 11, 2002
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Human Epilepsy Genetics–Neuronal Migration Disorders Study is a research trial aimed at finding out which genes are linked to conditions like epilepsy, brain malformations, and cognitive disorders, such as autism and intellectual disabilities. This study is currently looking for participants of all ages and genders who have these specific brain or cognitive disorders.
If you or someone you know has a brain malformation or a cognitive disorder, you may be eligible to join the study. Participants can expect to contribute to important research that may help improve understanding and treatment of these conditions. This trial is focused on identifying genetic factors, which could lead to better care and support for individuals affected by these disorders. Your involvement could make a difference in advancing medical knowledge in this area.
Gender
ALL
Eligibility criteria
- INCLUSION:
- • Males and females of any age.
- • Persons with a brain malformation or disorder of cognition (familial intellectual disability \[previously known as mental retardation\] or autism).
- EXCLUSION:
- • Persons without a brain malformation or disorder of cognition (familial intellectual disability (previously known as mental retardation\] or autism).
About Harvard University Faculty Of Medicine
Harvard University Faculty of Medicine is a prestigious academic institution renowned for its commitment to advancing medical knowledge and improving patient care through innovative research. As a leading sponsor of clinical trials, the Faculty of Medicine leverages its extensive resources, interdisciplinary collaboration, and expertise in various medical fields to conduct rigorous studies aimed at evaluating new treatments, therapies, and interventions. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing to the scientific community's understanding of health and disease.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Christopher A. Walsh, M.D., Ph.D.
Principal Investigator
Harvard Institutes of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials